This initiative serves to unite the efforts and resources of 4 partnering organizations, combining the efforts and expertise of colleagues from the International Vaccine Access Center at Johns Hopkins University (IVAC), Jhpiego, the Centre for the Evaluation of Vaccination at the University of Antwerp, and the Vaccine Confidence Project (VCP) at the London School of Hygiene and Tropical Medicine (LSHTM). Together, we are working to build and support optimized local programs, guide rapid country adoption of revisions in schedule recommendations, and accelerate HPV vaccine introduction. The overarching goal is efficient translation of implementation research findings to guide practice and more equitable access to immunization ideally within the context of a stable HPV vaccine market.
The goal of this project is to accelerate progress in HPV vaccine introduction, access, and program optimization in Gavi-eligible countries.
To reach this goal, we will work collectively to achieve the following primary and intermediate objectives/outcomes:
To foster the leadership of a robust community of practice around HPV vaccines that connects scientists, decision-makers and decision-influencers in country and global vaccine markets, in order to:
- Build consensus on best practices and the research agenda
- Strengthen, equip, and empower the HPV vaccine community of practice
- Build consensus on evidence for practices in policies, programs and research priorities
To provide and manage a platform that identifies and elevates voices of the global south to shape global science, policy and program dialogues on HPV vaccination, in order to:
- Increase translation and use of evidence to shape policies and programs
- Increase salience of HPV vaccination among regional and country decision-makers and key influencers in Gavi-eligible countries
This project is supported by the Bill & Melinda Gates Foundation.